Skip to main content
. 2015 Mar 12;6(11):8914–8928. doi: 10.18632/oncotarget.3563

Figure 7. Downregulation of miR-203 correlates with chemotherapy resistance and poor patient survival in GBM.

Figure 7

(A) Expression of SNAI2 and E-cadherin in resected human GBM specimen was assessed by immunohistochemistry assay. Scale bar, 100 μm. (B) Average expression levels of SNAI2 and E-cadherin in human primary GBM specimens and relapsed GBM tissues. (C) The expression of miR-203 was significantly reduced in relapsed GBM patients. (D) Kaplan-Meier overall survival curve according to miR-203 expression levels in GBM patients (p = 0.0017). *P < 0.05, **P < 0.01.